Pomeranian Medical University | Poland

Dr. Elżbieta Złowocka-Perłowska is an accomplished Polish medical scientist specializing in molecular oncology and hereditary cancer research. She earned her master’s degree in biology from the University of Szczecin and a doctorate in medical sciences with highest distinction from the Pomeranian Medical University in Szczecin, where she currently serves at the Center for Hereditary Tumors and the Department of Genetics and Pathomorphology. Her professional expertise lies in molecular diagnostics, cancer biomarkers, and the prognostic role of trace and microelements in bladder and kidney cancers. She leads innovative research investigating correlations between blood and serum element levels and patient survival, aiming to integrate these biomarkers into predictive cancer models for personalized therapy development. Dr. Złowocka-Perłowska possesses strong research skills in molecular genetics, laboratory diagnostics, epidemiological modeling, and translational oncology. Her distinguished career includes numerous national and international awards, such as recognition from the World Scientist Forum and multiple Rector’s Awards, along with significant contributions to over fifty scientific publications and several patents. She has also collaborated internationally and mentored emerging researchers. Through her pioneering work, Dr. Złowocka-Perłowska continues to advance the understanding of hereditary and molecular mechanisms in cancer, contributing to future innovations in clinical diagnostics and targeted therapies.